Cholesterol’s Star Role in Dementia Prevention: New Insights from the 2024 Lancet Dementia Report
Cardiometabolic Health Congress
AUGUST 23, 2024
The Dyslipidemia/Atherosclerosis/Thrombosis track will feature sessions on dyslipidemia and LDL cholesterol, including: LDL Lowering Therapy Beyond Statins Supported by an educational grant from Esperion Therapeutics. Challenging Lipid Management Cases & Panel Discussion & Audience Questions Moderator: Christie M.
Let's personalize your content